Monte Rosa Therapeutics Inc. – Filings and Transcripts

NASDAQ: GLUE
Share price (9/28/26): $11.71
Market cap (9/28/26): $999 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Automatic shelf registration

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Shelf registration

Ownership Filter

Montanova Capital, LLC

Vestal Point Capital, LP

Champoux Jennifer

News Filter

Announces Milestone Achievement Associated With Initiation of Phase 2 Clinical Study for VAV1-directed Molecular Glue Degrader MRT-6160

Announces Second Quarter 2026 Financial Results and Business Updates

Shareholder Vote Results

Announces First Quarter 2026 Financial Results and Business Updates

Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Updates

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission